Lantz Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.35M | Buy |
7,270
+269
| +4% | +$49.9K | 0.34% | 85 |
|
2025
Q1 | $1.47M | Buy |
7,001
+340
| +5% | +$71.2K | 0.4% | 77 |
|
2024
Q4 | $1.18M | Buy |
6,661
+210
| +3% | +$37.3K | 0.32% | 82 |
|
2024
Q3 | $1.27M | Buy |
6,451
+148
| +2% | +$29.2K | 0.34% | 79 |
|
2024
Q2 | $1.08M | Sell |
6,303
-247
| -4% | -$42.4K | 0.34% | 85 |
|
2024
Q1 | $1.19M | Sell |
6,550
-1,031
| -14% | -$188K | 0.38% | 76 |
|
2023
Q4 | $1.17M | Buy |
7,581
+876
| +13% | +$136K | 0.42% | 73 |
|
2023
Q3 | $999K | Buy |
6,705
+13
| +0.2% | +$1.94K | 0.4% | 70 |
|
2023
Q2 | $902K | Buy |
6,692
+40
| +0.6% | +$5.39K | 0.35% | 78 |
|
2023
Q1 | $1.06M | Buy |
6,652
+2,567
| +63% | +$409K | 0.44% | 71 |
|
2022
Q4 | $660K | Buy |
4,085
+40
| +1% | +$6.46K | 0.3% | 85 |
|
2022
Q3 | $543K | Buy |
4,045
+20
| +0.5% | +$2.69K | 0.28% | 84 |
|
2022
Q2 | $616K | Sell |
4,025
-615
| -13% | -$94.1K | 0.28% | 85 |
|
2022
Q1 | $752K | Sell |
4,640
-303
| -6% | -$49.1K | 0.31% | 84 |
|
2021
Q4 | $669K | Buy |
4,943
+329
| +7% | +$44.5K | 0.31% | 81 |
|
2021
Q3 | $498K | Sell |
4,614
-39
| -0.8% | -$4.21K | 0.26% | 92 |
|
2021
Q2 | $524K | Buy |
4,653
+651
| +16% | +$73.3K | 0.27% | 87 |
|
2021
Q1 | $433K | Buy |
4,002
+218
| +6% | +$23.6K | 0.25% | 81 |
|
2020
Q4 | $405K | Sell |
3,784
-12,269
| -76% | -$1.31M | 0.25% | 80 |
|
2020
Q3 | $1.41M | Sell |
16,053
-49
| -0.3% | -$4.29K | 0.95% | 31 |
|
2020
Q2 | $1.58M | Sell |
16,102
-224
| -1% | -$22K | 1.14% | 21 |
|
2020
Q1 | $1.24M | Buy |
16,326
+13,028
| +395% | +$993K | 0.97% | 27 |
|
2019
Q4 | $292K | Buy |
3,298
+118
| +4% | +$10.4K | 0.17% | 111 |
|
2019
Q3 | $229K | Buy |
3,180
+56
| +2% | +$4.03K | 0.15% | 114 |
|
2019
Q2 | $232K | Buy |
3,124
+236
| +8% | +$17.5K | 0.16% | 113 |
|
2019
Q1 | $233K | Buy |
+2,888
| New | +$233K | 0.17% | 104 |
|